Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success

Business - Latest - Google News · August 19, 2026

Moderna Shares Rocket 110% Pre-Market As Cancer Drug Trial Success  NDTV ProfitModerna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock is soaring.  MarketWatchModerna Shares Skyrocket 125% Toward Best Day Ever—Here’s Why  ForbesPromising Results for mRNA Cancer Vaccine from Moderna and Merck  Time MagazineBrookline reiterates Moderna stock rating on positive melanoma data By Investing.com  Investing.com India

View original source →

More News

EXCLUSIVE: Alibaba plans to charge big users of its next open-source AI model, sources say
Electric 2W Retail Sales July 2026 – EV Share Crosses 11%
Google CEO Sundar Pichai in email to employees on Jeff Dean leaving after 27 years and Demis Hassabis' ne
Gold holds near two-month high as equities slip, oil rallies – Kitco PM Report